The neural androgen receptor: A therapeutic target for myelin repair in chronic demyelination

Brain

Volumn 136, Issue 1, 2013, Pages 132-146

  Hussain, Rashad ^a,b   Ghoumari, Abdel M ^a   Bielecki, Bartosz ^a   Steibel, Jérôme ^b   Boehm, Nelly ^c   Liere, Philippe ^a   MacKlin, Wendy B ^d   Kumar, Narender ^e   Habert, René ^c   Mhaouty Kodja, Sakina ^f   Tronche, François ^f   Sitruk Ware, Regine ^e   Schumacher, Michael ^a   Ghandour, M Said ^b  

^a Universite Paris Sud   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c INSERM   (France)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e ROCKEFELLER UNIVERSITY   (United States)

^f SORBONNE UNIVERSITÉ   (France)

Author keywords

androgen receptor; multiple sclerosis; myelin; remyelination; testosterone

Indexed keywords

ANDROSTANOLONE; CUPRIZONE; FLUTAMIDE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL COUNT; CONTROLLED STUDY; DEMYELINATION; FEMALE; MACROGLIA; MALE; MICROGLIA; MOUSE; MYELIN SHEATH; NONHUMAN; PRIORITY JOURNAL; REMYELINIZATION;

EID: 84873336400     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws284     Document Type: Article

References (68)

1. Anderson RA, Wallace AM, Sattar N, Kumar N, Sundaram K. Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men. J Clin Endocrinol Metab 2003; 88: 2784-93.
2. Askew EB, Gampe RT Jr, Stanley TB, Faggart JL, Wilson EM. Modulation of androgen receptor activation function 2 by testosterone and di- hydrotestosterone. J Biol Chem 2007; 282: 25801-16.
3. Birgbauer E, Rao TS, Webb M. Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. J Neurosci Res 2004; 78: 157-66.
4. Blakemore WF, Franklin RJ. Remyelination in experimental models of toxin-induced demyelination. Curr Top Microbiol Immunol 2008; 318: 193-212.
5. Cerghet M, Skoff RP, Bessert D, Zhang Z, Mullins C, Ghandour MS. Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents. J Neurosci 2006; 26: 1439-47.
6. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000; 20: 6404-12.
7. Chang A, Tourtellotte WW, Rudick R, Trapp BD. Premyelinating oligo-dendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002; 346: 165-73.
8. Chen J, Sowers MR, Moran FM, McConnell DS, Gee NA, Greendale GA, et al. Circulating bioactive androgens in midlife women. J Clin Endocrinol Metab 2006; 91: 4387-94.
9. Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain 2006; 129: 595-605.
10. Deboy CA, Zhang J, Dike S, Shats I, Jones M, Reich DS, et al. High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. Brain 2007; 130: 2199-210.
11. De Gendt K, Swinnen JV, Saunders PT, Schoonjans L, Dewerchin M, Devos A, et al. A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. Proc Natl Acad Sci USA 2004; 101: 1327-32.
12. DonCarlos LL, Garcia-Ovejero D, Sarkey S, Garcia-Segura LM, Azcoitia I. Androgen receptor immunoreactivity in forebrain axons and dendrites in the rat. Endocrinology 2003; 144: 3632-38.
13. Fargo KN, Foecking EM, Jones KJ, Sengelaub DR. Neuroprotective actions of androgens on motoneurons. Front Neuroendocrinol 2009; 30: 130-41.
14. Franklin RJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002; 3: 705-14.
15. Franklin RJ, ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 2008; 9: 839-55.
16. Fromont A, Binquet C, Sauleau EA, Fournel I, Bellisario A, Adnet J, et al. Geographic variations of multiple sclerosis in France. Brain 2010; 133: 1889-99.
17. Garcia-Ovejero D, Veiga S, Garcia-Segura LM, DonCarlos LL. Glial expression of estrogen and androgen receptors after rat brain injury. J Comp Neurol 2002; 450: 256-71.
18. Garcia-Segura LM, Veiga S, Sierra A, Melcangi RC, Azcoitia I. Aromatase: a neuroprotective enzyme. Prog Neurobiol 2003; 71: 31-41.
19. Gaspar ML, Meo T, Bourgarel P, Guenet JL, Tosi M. A single base deletion in the Tfm androgen receptor gene creates a short-lived messenger RNA that directs internal translation initiation. Proc Natl Acad Sci USA 1991; 88: 8606-10.
20. Ghoumari AM, Baulieu EE, Schumacher M. Progesterone increases oligo-dendroglial cell proliferation in rat cerebellar slice cultures. Neuroscience 2005; 135: 47-58.
21. Gold SM, Chalifoux S, Giesser BS, Voskuhl RR. Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone. J Neuroinflammation 2008; 5: 32.
22. Gold SM, Voskuhl RR. Estrogen treatment in multiple sclerosis. J Neurol Sci 2009; 286: 99-103.
23. Harsan LA, Steibel J, Zaremba A, Agin A, Sapin R, Poulet P, et al. Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging. J Neurosci 2008; 28: 14189-201.
24. Heemers HV, Tindall DJ. Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev 2007; 28: 778-808.
25. Hussain R, El-Etr M, Gaci O, Rakotomamonjy J, Macklin WB, Kumar N, et al. Progesterone and nestorone facilitate axon remyelination: a role for progesterone receptors. Endocrinology 2011; 152: 3820-31.
26. Howell OW, Rundle JL, Garg A, Komada M, Brophy PJ, Reynolds R. Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J Neuropathol Exp Neurol 2010; 69: 1017-33.
27. Jalabi W, Boehm N, Grucker D, Ghandour MS. Recovery of Myelin after Induction of Oligodendrocyte cell death in postnatal brain. J Neurosci 2005; 25: 2886-94.
28. James PJ, Nyby JG, Saviolakis GA. Sexually stimulated testosterone release in male mice (Mus musculus): roles of genotype and sexual arousal. Horm Behav 2006; 50: 424-31.
29. Kieseier BC, Stuve O. A critical appraisal of treatment decisions in multiple sclerosis-old versus new. Nat Rev Neurol 2011; 7: 255-62.
30. Kipp M, Clarner T, Dang J, Copray S, Beyer C. The cuprizone animal model: new insights into an old story. Acta Neuropathol 2009; 118: 723-36.
31. Kuhlmann T, Miron V, Cuo Q, Wegner C, Antel J, Bruck W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008; 131: 1749-58.
32. Kumar N, Suvisaari J, Tsong YY, Aguillaume C, Bardin CW, Lähteenmaki P, et al. Pharmacokinetics of 7 alpha-methyl-19-nortestosterone in men and cynomolgus monkeys. J Androl 1997; 18: 352-8.
33. Lee Y, Morisson BM, Li Y, Lengacher S, Farah MH, Hofman PN, et al. Oligodendroglia metabolically support axons and contribute to neuro-degeneration. Nature 2012; 487: 443-8.
34. Li WW, Setzu A, Zhao C, Franklin RJ. Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J Neuroimmunol 2005; 158: 58-66.
35. Li WW, Penderis J, Zhao C, Schumacher M, Franklin RJM. Females remyelinate more efficiently than males following demyelination in the aged but not young adult CNS. Exp Neurol 2006; 202: 250-4.
36. Liere P, Pianos A, Eychenne B, Cambourg A, Bodin K, Griffiths W, et al. Analysis of pregnenolone and dehydroepiandrosterone in rodent brain: cholesterol autoxidation is the key. J Lipid Res 2009; 50: 2430-44.
37. Ligon KL, Fancy SP, Franklin RJ, Rowitch DH. Olig gene function in CNS development and disease. Glia 2006; 54: 1-10.
38. Liva SM, Voskuhl RR. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol 2001; 167: 2060-7.
39. Lorenz B, Garcia-Segura LM, DonCarlos LL. Cellular phenotype of androgen receptor-immunoreactive nuclei in the developing and adult rat brain. J Comp Neurol 2005; 492: 456-68.
40. Lu SF, McKenna SE, Cologer-Clifford A, Nau EA, Simon NG. Androgen receptor in mouse brain: sex differences and similarities in autoregulation. Endocrinology 1998; 139: 1594-601.
41. Maire CL, Wegener A, Kerninon C, Nait OB. Gain-of-function of Olig transcription factors enhances oligodendrogenesis and myelination. Stem Cells 2010; 28: 1611-22.
42. Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cyto-kines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 2004; 89: 3313-8.
43. Mallon BS, Shick HE, Kidd GJ, Macklin WB. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci 2002; 22: 876-85.
44. Martino G, Franklin RJ, Baron Van EA, Kerr DA. Stem cell transplantation in multiple sclerosis: current status and future prospects. Nat Rev Neurol 2010; 6: 247-55.
45. Mason JL, Toews A, Hostettler JD, Morell P, Suzuki K, Goldman JE, et al. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol 2004; 164: 1673-82.
46. Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 2001; 11: 107-16.
47. Merlet J, Racine C, Moreau E, Moreno SG, Habert R. Male fetal germ cells are targets for androgens that physiologically inhibit their proliferation. Proc Natl Acad Sci USA 2007; 104: 3615-20.
48. Nyby JG. Reflexive testosterone release: a model system for studying the nongenomic effects of testosterone upon male behavior. Front Neuroendocrinol 2008; 29: 199-210.
49. Page ST, Plymate SR, Bremner WJ, Matsumoto AM, Hess DL, Lin DW, et al. Effect of medical castration on CD4 + CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and/or its metabolites. Am J Physiol Endocrinol Metab 2006; 290: E856-63.
50. Palaszynski KM, Loo KK, Ashouri JF, Liu HB, Voskuhl RR. Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol 2004; 146: 144-52.
51. Piaton G, Williams A, Seilhean D, Lubetzki C. Remyelination in multiple sclerosis. Prog Brain Res 2009; 175: 453-64.
52. Prasad PV, Arumugam R, Willman M, Ge RS, Sitruk-Ware R, Kumar N. Distribution, metabolism and excretion of a synthetic androgen 7alpha-methyl-19-nortestosterone, a potential male-contraceptive. Steroids 2009; 74: 121-31.
53. Raskin K, De GK, Duittoz A, Liere P, Verhoeven G, Tronche F, et al. Conditional inactivation of androgen receptor gene in the nervous system: effects on male behavioral and neuroendocrine responses. J Neurosci 2009; 29: 4461-70.
54. Richardson WD, Young KM, Tripathi RB, McKenzie I. NG2-glia as multipotent neural stem cells: fact or fantasy? Neuron 2011; 70: 661-73.
55. Rosario ER, Chang L, Stanczyk FZ, Pike CJ. Age-related testosterone depletion and the development of Alzheimer disease. JAMA 2004; 292: 1431-2.
56. Safarinejad MR. Evaluation of endocrine profile, hypothalamic-pituitary- testis axis and semen quality in multiple sclerosis. J Neuroendocrinol 2008; 20: 1368-75.
57. Sicotte NL, Giesser BS, Tandon V, Klutch R, Steiner B, Drain AE, et al. Testosterone treatment in multiple sclerosis: a pilot study. Arch Neurol 2007; 64: 683-8.
58. Smith-Bouvier DL, Divekar AA, Sasidhar M, Du S, Tiwari-Woodruff SK, King JK, et al. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 2008; 205: 1099-108.
59. Talbott JF, Loy DN, Liu Y, Qiu MS, Bunge MB, Rao MS, et al. Endogenous Nkx2.2+/Olig2 + oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp Neurol 2005; 192: 11-24.
60. Tomassini V, Onesti E, Mainero C, Giugni E, Paolillo A, Salvetti M, et al. Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry 2005; 76: 272-5.
61. Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 2008; 31: 247-69.
62. Tripathi RB, Rivers LE, Young KM, Jamen F, Richardson WD. NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. J Neurosci 2010; 30: 16383-90.
63. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 1999; 23: 99-103.
64. van der Star BJ, Vogel DY, Kipp M, Puentes F, Baker D, Amor S. In vitro and in vivo models of multiple sclerosis. CNS Neurol Disord Drug Targets 2012; 11: 570-88.
65. von Eckardstein S, Noe G, Brache V, Nieschlag E, Croxatto H, Alvarez F, et al. A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. J Clin Endocrinol Metab 2003; 88: 5232-9.
66. Wei T, Lightman SL. The neuroendocrine axis in patients with multiple sclerosis. Brain 1997; 120: 1067-76.
67. Wake H, Lee PR, Fields RD. Control of local protein synthesis and initial events in myelination by action potentials. Science 2011; 333: 1647-51.
68. Zuloaga DG, Puts DA, Jordan CL, Breedlove SM. The role of androgen receptors in the masculinization of brain and behavior: what we've learned from the testicular feminization mutation. Horm Behav 2008; 53: 613-26.